Insights from experience is an educational Kineticos series on various strategic topics in the life sciences industry. Hear from our experts as they break down topics like how to conduct primary research studies, how to have a successful licensing meeting, and how to operate in a virtual world.


Deal Structure and Asset Valuation

A conversation with Philip Gialenios, Chief Commercial Officer and Nathan Finger, Director of Operations

Learn the keys to creating a deal structure and asset valuation from the components, when to create it, and why it is important in the licensing process. This video is approximately 6 minutes long.

Click here to watch the full video.


Bridges and Barriers to Advancing CAR-T Therapy – Part 2

Continuing a conversation between Kineticos’ Operating Executive, Steve Buckanavage and Dr. Jeffrey Skolnik, VP of Clinical Development at Inovio Pharmaceuticals

Kineticos’ Operating Executive, Steve Buckanavage, continues his conversation Dr. Jeffrey Skolnik, VP of Clinical Development at Inovio Pharmaceuticals. They start off their discussion by answering the question “If you were starting a clinical program today, what would the requirements be for starting a basket trial that includes hematological, as well as solid tumors?”

Click here to read the full conversation.


Bridges and Barriers to Advancing CAR-T Therapy – Part 1

A conversation between Kineticos’ Operating Executive, Steve Buckanavage and Dr. Jeffrey Skolnik, VP of Clinical Development at Inovio Pharmaceuticals

Oncology therapy programs utilizing the latest immune mediated technology have exploded over the last decade. With the advance of checkpoint inhibitors, new and different molecular diagnostic tests, and more recently, engineered cell therapies, vast new avenues have opened up to effectively treat greater numbers of patients. Kineticos’ Operating Executive, Steve Buckanavage, caught up with Dr. Jeffrey Skolnik, VP of Clinical Development at Inovio Pharmaceuticals to discuss some of these very topics.

Click here to read the full conversation.


Licensing in a Virtual World

Taught by Philip Gialenios, Chief Commercial Officer

How to conduct licensing in a virtual world. Learn the key components of interacting virtually with potential clients as well as the benefits and challenges of a virtual environment. This video is approximately 4 minutes long. For more detailed information, please view some papers on the topic below.

Click here to watch the full video.


The Value of Primary Research

Taught by Abe Maingi, VP of Precision Medicine

What is primary research and why is it important to the life sciences industry? Learn the key components of a successful primary research study and how to leverage the information gained. This video is approximately 6 minutes long.

Click here to watch the full video.


How to Have a Successful Licensing Program

Taught by Nathan Finger, Director of Operations

What is a licensing program and why is it important to the life sciences industry? Learn the key components of a successful licensing strategy and how to conduct a successful meeting. This video is less than 3 minutes long.

Click here to watch the full video.